(Q45855947)

17 December 2017

title

Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy (English)

1 reference

17 December 2017

0 references

M V Olson

1

1 reference

17 December 2017

J Lee

2

1 reference

17 December 2017

F Zhang

3

1 reference

17 December 2017

A Wang

4

1 reference

17 December 2017

Z Dong

5

1 reference

17 December 2017

publication date

10 February 2006

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

page(s)

676-685

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700941

exact match

0 references

cites work

Action of spontaneously produced beta interferon in differentiation of embryonal carcinoma cells through an autoinduction mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Interferon-beta induces S phase accumulation selectively in human transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Interferons and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Interferons alpha and beta as immune regulators--a new look

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Expression of vascular endothelial growth factor in human gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Why do so many cancer patients fail to respond to interferon therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Interferon-beta gene therapy improves survival in an immunocompetent mouse model of carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Interferon-mediated anti-angiogenic therapy for neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Pathophysiological chemistry of nitric oxide and its oxygenation by-products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Mammalian nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Molecular cloning of F4/80-like-receptor, a seven-span membrane protein expressed differentially by dendritic cell and monocyte-macrophage subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Endothelin-1 inhibits apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Differential induction of IL-12 by IFN-beta and IFN-gamma in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Type I interferons keep activated T cells alive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Identity of the proliferating cell nuclear antigen and cyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Molecular and functional aspects of PECAM-1/CD31

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Interferon-beta prevents the upregulation of interleukin-8 expression in human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Antiproliferative effect of interferons on human prostate carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Growth-inhibitory activity of interferon-beta against human colorectal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Hyperthermic isolated limb perfusion with intra-arterial administration of carboplatin and/or interferon-beta for the treatment of malignant melanoma of the leg

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Enhanced in vivo sensitivity of in vitro interferon-treated B16 melanoma cells to CD8 cells and activated macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Effect of murine interferon alpha/beta on tumour-induced suppressor function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700941

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700941

1 reference

17 December 2017

Dimensions Publication ID

1023279357

0 references

1 reference

17 December 2017